Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in FNA, biopsy, and resection specimens.
Dana RazzanoSoumar J BouzaPatricia V HernandezMinhua WangMarie E RobertZenta WaltherGuoping CaiPublished in: Cancer cytopathology (2022)
Our study demonstrated similar success rates for comprehensive molecular analysis using FNA and FNB specimens of PDAC, suggesting that FNA material could serve as an alternative source for comprehensive molecular testing. The molecular alterations identified in these specimens may have potential diagnostic and therapeutic implications.